Suppr超能文献

基于聚吡咯的纳米诊疗剂用于三阴性乳腺癌的可激活荧光成像及化学/光热联合治疗

Polypyrrole-based nanotheranostics for activatable fluorescence imaging and chemo/photothermal dual therapy of triple-negative breast cancer.

作者信息

Park Dongjin, Ahn Kyung-Ohk, Jeong Kyung-Chae, Choi Yongdoo

机构信息

Molecular Imaging and Therapy Branch, National Cancer Center, 323 Ilsan-ro, Goyang-si, Gyeonggi-do 10408, Korea.

出版信息

Nanotechnology. 2016 May 6;27(18):185102. doi: 10.1088/0957-4484/27/18/185102. Epub 2016 Mar 23.

Abstract

Here, we fabricated polypyrrole nanoparticles (PPys) (termed HA10-PPy, HA20-PPy, and HA40-PPy) doped with different average molecular weight hyaluronic acids (HAs) (10, 20, and 40 kDa, respectively), and evaluated the effect of molecular weight of doped HA on photothermal induction, fluorescence quenching, and drug loading efficiencies. Doxorubicin-loaded HA-doped PPys (DOX@HA-PPys) could be used for imaging and therapy of triple-negative breast cancer (TNBC). Fluorescence turn-on, stimuli-responsive drug release, and photo-induced heating of DOX@HA-PPys enabled not only activatable fluorescence imaging but also subsequent chemo/photothermal dual therapy for TNBC. In particular, we illustrated the potential usefulness of the photothermal effect of the nanoparticles for overcoming chemoresistance in TNBC.

摘要

在此,我们制备了掺杂不同平均分子量透明质酸(HA)(分别为10 kDa、20 kDa和40 kDa)的聚吡咯纳米颗粒(PPy)(称为HA10-PPy、HA20-PPy和HA40-PPy),并评估了掺杂HA的分子量对光热诱导、荧光猝灭和药物负载效率的影响。负载阿霉素的HA掺杂PPy(DOX@HA-PPy)可用于三阴性乳腺癌(TNBC)的成像和治疗。DOX@HA-PPy的荧光开启、刺激响应性药物释放和光诱导加热不仅实现了可激活荧光成像,还实现了对TNBC的后续化学/光热联合治疗。特别是我们阐述了纳米颗粒的光热效应在克服TNBC化疗耐药性方面的潜在用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验